Oncogenic activation of p21(ras) or pp60(c-src) in human colonic Caco-2 cells is associated with post-translational alterations of syndecan-1;L'activation oncogenique de p21(ras) ou pp60(c-src) dans les cellules coliques humaines Caco-2 induit des alterations post-traductionnelles du syndecan-1

Bulletin du Cancer

Volumn 84, Issue 3, 1997, Pages 235-237

  Lévy, Peggy ^a   Munier, Annie ^a   Baron Delage, Sophie ^a   Chastre, Eric ^b   Gespach, Christian ^b   Capeau, Jacqueline ^a   Cherqui, Gisèle ^a  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

human colonic Caco 2 cells; polyoma middle T; pp60(c src); ras; syndecan 1

Indexed keywords

HEPARANASE; ONCOPROTEIN; PROTEIN P21; PROTEOGLYCAN; SYNDECAN 1; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; CHONDROITIN SULFATE; GLYCOSIDASE; HEPARAN SULFATE; MEMBRANE PROTEIN; PROTEIN KINASE P60; SDC1 PROTEIN, HUMAN; SYNDECAN; VIRUS T ANTIGEN;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE H RAS; ONCOGENE SRC; TUMOR CELL LINE; VIRUS ONCOGENE; BIOSYNTHESIS; CELL STRAIN CACO 2; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; METABOLISM; ONCOGENE RAS; PROTEIN PROCESSING;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; CACO-2 CELLS; CHONDROITIN SULFATES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TRANSFER TECHNIQUES; GENES, RAS; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HEPARITIN SULFATE; HUMANS; MEMBRANE GLYCOPROTEINS; ONCOGENE PROTEIN P21(RAS); ONCOGENE PROTEIN PP60(V-SRC); PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOGLYCANS; SYNDECAN-1; SYNDECANS;

EID: 0030906030     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Buee L, Boyle NJ, Zhang L, Delacourte A, Fillit HM. Optimization of an alcian blue dot-blot assay for the detection of glycosaminoglycons and proteoglycans. Anal Biochem 1991; 195: 238-42.
2. Chastre E, Empereur S, Di Gioia Y, El Madhani N, Mareel M, Vleminckx K, Van Roy F, Bex V, Emami S, Spandidos DA, Gespach C. Neoplastic progression of human and rat intestinal cell lines after transfer of the ras and polyoma middle T oncogenes. Gastroenterology 1993; 105: 1776-89.
3. Iozzo RV, Sampson PM, Schmitt GK. Neoplastic modulation of extracellular matrix: stimulation of chondroitin sulfate proteoglycan and hyaluronic acid synthesis in co-cultures of human colon carcinoma and smooth muscle cells. J Cell Biochem 1989; 39: 355-78.
4. Jalkanen M, Rapraeger A, Bernfield M. Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol 1987; 105: 3087-96.
5. Laurent-Puig P. Colorectal cancer. Bull Cancer 1994; 81 (suppl. 1): 27s-31s.
6. Lévy P, Emami S, Cherqui G, Chastre E, Gespach C, Picard J. Altered expression of proteogycans in E1A-immortalized rat fetal intestinal epithalial cells in culture. Cancer Res 1990; 50: 6716-22.
7. Lévy P, Munier A, Baron-Delage S, Dí Gioia Y, Gespach C, Capeau J, Cherqui G. Syndecan-1 alterations during the tumorigenic progression of human colonic Coco-2 cells induced by human Ho-ras or polyoma middle T oncogenes. Brit J Cancer 1996; 74: 423-31.
8. Rapraeger AC. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Cur Opin Cell Biol 1993; 5: 844-53.
9. Wasteson A. A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J Chromat 1971; 59: 87-97.